Methotrexate vs Certolizumab pegol
National NHS prescribing compared (Prescription Cost Analysis)
Methotrexate was dispensed 187,649.0× as often as Certolizumab pegol in April 2026 — 187,649 items versus 1 in England.
187,649items
Methotrexate · April 2026
NHSBSA Prescription Cost Analysis
1items
Certolizumab pegol · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Methotrexate versus Certolizumab pegol: national items dispensed by month
▬ Methotrexate · ╌ Certolizumab pegol
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Methotrexate | Certolizumab pegol |
|---|---|---|
| Items, April 2026 | 187,649 | 1 |
| Items, last 12 months | 2,242,345 | 6 |
| Net ingredient cost, April 2026 | £2,311,461 | £358 |
See the full profile for Methotrexate or Certolizumab pegol.